New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 12, 2021 - Genentech announced the FDA approval of Xolair (omalizumab) prefilled syringe for self-injection across all its approved indications.
Download PDF
Return to publications
